We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+17.39%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.66B
AUM Growth
+$537M
Cap. Flow
-$23.3M
Cap. Flow %
-0.5%
Top 10 Hldgs %
6.44%
Holding
1,468
New
106
Increased
604
Reduced
314
Closed
113

Top Buys

Rank Stock Value
1
XRX icon
Xerox
XRX
+$14.1M
2
DAN icon
Dana Inc
DAN
+$12.5M
3
OPEN icon
Opendoor
OPEN
+$10.6M
4
CSCO icon
Cisco
CSCO
+$7.51M
5
JBLU icon
JetBlue
JBLU
+$7.32M

Sector Composition

Rank Sector Weight
1 Financials 26.7%
2 Consumer Discretionary 12.75%
3 Industrials 12.29%
4 Technology 10.9%
5 Healthcare 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
1101
AbbVie
ABBV
$435B
$242K 0.01%
1,559
-300
-16% -$43.7K
LVLU icon
1102
Lulu's Fashion Lounge
LVLU
$52.3M
$238K 0.01%
8,527
+160
+2% +$5.17K
VATE icon
1103
INNOVATE Corp
VATE
$165M
$237K 0.01%
19,300
-2,500
-11% -$30.6K
BARK icon
1104
BARK
BARK
$101M
$236K 0.01%
14,662
+4,662
+47% +$85K
MAPS
1105
DELISTED
WM TECHNOLOGY INC A
MAPS
$236K 0.01%
327,700
+61,300
+23% +$60.9K
UBCP icon
1106
United Bancorp
UBCP
$96M
$236K 0.01%
18,509
FEIM icon
1107
Frequency Electronics
FEIM
$816M
$235K 0.01%
21,500
CLPR
1108
Clipper Realty
CLPR
$46.2M
$231K 0.01%
42,763
+15,900
+59% +$79.8K
LTRX icon
1109
Lantronix
LTRX
$266M
$231K 0.01%
+39,400
New +$198K
THRX
1110
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$231K 0.01%
+57,000
New +$174K
TACT icon
1111
Transact Technologies
TACT
$58.6M
$230K ﹤0.01%
33,000
KTCC icon
1112
Key Tronic
KTCC
$44.7M
$229K ﹤0.01%
52,900
VERI icon
1113
Veritone
VERI
$122M
$226K ﹤0.01%
125,000
+25,000
+25% +$55.7K
AREN icon
1114
Arena Group
AREN
$83.8M
$226K ﹤0.01%
94,800
INZY
1115
DELISTED
Inozyme Pharma
INZY
$221K ﹤0.01%
51,800
-39,883
-44% -$142K
LPTV
1116
DELISTED
Loop Media, Inc.
LPTV
$219K ﹤0.01%
219,000
PED icon
1117
PEDEVCO
PED
$141M
$218K ﹤0.01%
14,165
-4,410
-24% -$77.5K
MNOV icon
1118
MediciNova
MNOV
$66M
$218K ﹤0.01%
145,147
GEG icon
1119
Great Elm Group
GEG
$69.3M
$217K ﹤0.01%
112,014
+192
+0.2% +$372
IRIX icon
1120
IRIDEX
IRIX
$14.5M
$217K ﹤0.01%
77,100
SSY
1121
DELISTED
SunLink Health Systems
SSY
$217K ﹤0.01%
232,800
KNTE
1122
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$216K ﹤0.01%
91,300
-53,000
-37% -$93.8K
BFLY icon
1123
Butterfly Network
BFLY
$2.35B
$216K ﹤0.01%
+200,000
New +$198K
USCB icon
1124
USCB Financial Holdings
USCB
$412M
$214K ﹤0.01%
17,500
ZFOX
1125
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
$213K ﹤0.01%
244,900

Similar funds

Bridgeway Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Bridgeway Capital Management held 1,468 positions worth $4.66B, up 13% from $4.12B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Bridgeway Capital Management's Q4 2023 filing shows 106 new, 604 increased, 314 reduced and 113 closed positions. Its largest new stake was Xerox: 953,092 shares worth $17.5M. The largest sale was Textainer Group Holdings limited, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q4 2023 buy was Xerox: 953,092 shares worth $17.5M.
  • Bridgeway Capital Management added most to Opendoor in Q4 2023, an estimated $10.6M increase.
  • Bridgeway Capital Management's biggest Q4 2023 reduction was Textainer Group Holdings limited, cutting an estimated $19.1M.
  • Bridgeway Capital Management fully exited VERITIV CORPORATION in Q4 2023, selling an estimated $13M.
  • Bridgeway Capital Management's ten largest holdings make up 6.4% of its $4.66B portfolio in Q4 2023.
  • Bridgeway Capital Management opened 106 new positions and closed 113 in Q4 2023.
  • Bridgeway Capital Management's portfolio value rose 13% quarter-over-quarter to $4.66B.

Based on Bridgeway Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.